The landscape of diabetes management is rapidly changing , with the emergence of dual GIP and GLP-1 receptor agonists. Both The Tirzepatide and Retatru tide represent significant advancements; Tirzepatide https://hamzahbpnz413882.digitollblog.com/42853709/tirzepatid-retatru-tide-a-revolutionary-metabolic-partnership